• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫“冷”型三阴性乳腺癌在患者来源的异种移植模型中具有更高的移植率。

Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.

作者信息

Petrosyan Varduhi, Dobrolecki Lacey E, LaPlante Emily L, Srinivasan Ramakrishnan Rajaram, Bailey Matthew H, Welm Alana L, Welm Bryan E, Lewis Michael T, Milosavljevic Aleksandar

机构信息

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.

出版信息

NPJ Breast Cancer. 2022 Sep 10;8(1):104. doi: 10.1038/s41523-022-00476-0.

DOI:10.1038/s41523-022-00476-0
PMID:36088362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9464188/
Abstract

TNBC is a heterogeneous subtype of breast cancer, and only a subset of TNBC can be established as PDXs. Here, we show that there is an engraftment bias toward TNBC with low levels of immune cell infiltration. Additionally, TNBC that failed to engraft show gene expression consistent with a cancer-promoting immunological state, leading us to hypothesize that the immunological state of the tumor and possibly the state of the immune system of the host may be essential for engraftment.

摘要

三阴性乳腺癌(TNBC)是乳腺癌的一种异质性亚型,只有一部分TNBC能够被建立为移植瘤模型(PDXs)。在此,我们表明,对于免疫细胞浸润水平低的TNBC存在植入偏向性。此外,未能成功植入的TNBC表现出与促癌免疫状态一致的基因表达,这使我们推测肿瘤的免疫状态以及宿主免疫系统的状态可能对植入至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7528/9464188/9939b71ed660/41523_2022_476_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7528/9464188/9939b71ed660/41523_2022_476_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7528/9464188/9939b71ed660/41523_2022_476_Fig1_HTML.jpg

相似文献

1
Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.免疫“冷”型三阴性乳腺癌在患者来源的异种移植模型中具有更高的移植率。
NPJ Breast Cancer. 2022 Sep 10;8(1):104. doi: 10.1038/s41523-022-00476-0.
2
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.非裔美国人和白种人女性中三阴性乳腺癌的免疫微环境。
Breast Cancer Res Treat. 2019 May;175(1):247-259. doi: 10.1007/s10549-019-05156-5. Epub 2019 Feb 6.
3
Functional characterization of androgen receptor in two patient-derived xenograft models of triple negative breast cancer.雄激素受体在两种三阴性乳腺癌患者来源异种移植模型中的功能特征。
J Steroid Biochem Mol Biol. 2021 Feb;206:105791. doi: 10.1016/j.jsbmb.2020.105791. Epub 2020 Nov 30.
4
Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers.三阴性乳腺癌患者来源异种移植模型中植入相关基因的预后及功能重要性
Breast Cancer Res Treat. 2015 Nov;154(1):13-22. doi: 10.1007/s10549-015-3585-y. Epub 2015 Oct 5.
5
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.评估抗 PD-1 疗法对人源化小鼠模型中移植的三阴性乳腺癌患者来源异种移植肿瘤的疗效。
Breast Cancer Res. 2018 Sep 5;20(1):108. doi: 10.1186/s13058-018-1037-4.
6
Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.调节性 T 细胞与三阴性乳腺癌的肿瘤免疫微环境和免疫治疗反应有关。
Front Immunol. 2023 Sep 12;14:1263537. doi: 10.3389/fimmu.2023.1263537. eCollection 2023.
7
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.在恩扎卢胺耐药的腔面雄激素受体三阴性乳腺癌患者来源异种移植模型中对 mTOR 和 PI3K 抑制剂的反应。
Theranostics. 2020 Jan 1;10(4):1531-1543. doi: 10.7150/thno.36182. eCollection 2020.
8
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.三阴性乳腺癌患者来源异种移植物再现患者肿瘤的分子特征,并对 mTOR 抑制有反应。
Breast Cancer Res. 2014 Apr 7;16(2):R36. doi: 10.1186/bcr3640.
9
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.三阴性乳腺癌的组织蛋白酶 D 靶向抗体免疫治疗。
J Immunother Cancer. 2019 Feb 4;7(1):29. doi: 10.1186/s40425-019-0498-z.
10
Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).与患者来源的肿瘤植入物(患者来源的异种移植)在小鼠体内生长相关的患者特征
Cancers (Basel). 2023 Nov 14;15(22):5402. doi: 10.3390/cancers15225402.

引用本文的文献

1
The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer.人自然杀伤细胞对乳腺癌三维异型细胞肿瘤模型的活性
Cells. 2025 Jul 8;14(14):1039. doi: 10.3390/cells14141039.
2
Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.为他人带来希望(我们的组织助力提升研究与科学):匹兹堡大学乳腺癌快速尸检项目的研究成果
Breast Cancer Res. 2025 Jun 19;27(1):111. doi: 10.1186/s13058-025-02014-9.
3
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.

本文引用的文献

1
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.用于药物发现和精准肿瘤学的人乳腺癌衍生异种移植和类器官平台。
Nat Cancer. 2022 Feb;3(2):232-250. doi: 10.1038/s43018-022-00337-6. Epub 2022 Feb 24.
2
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer.CIBERSORT 分析 TCGA 和 METABRIC 数据,确定三阴性乳腺癌中具有更好预后的亚组。
Sci Rep. 2021 Feb 25;11(1):4691. doi: 10.1038/s41598-021-83913-7.
3
Tumor-Associated Macrophages in Tumor Immunity.
重编程乳腺肿瘤免疫微环境:从冷到热的转变以增强免疫治疗
J Exp Clin Cancer Res. 2025 Apr 25;44(1):131. doi: 10.1186/s13046-025-03394-8.
4
Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country.源自一个南美国家的乳腺癌患者来源异种移植瘤的类固醇激素受体、外显子组测序与治疗反应性
Sci Rep. 2025 Jan 18;15(1):2415. doi: 10.1038/s41598-025-86389-x.
5
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.三阴性乳腺癌患者来源的异种移植模型可实现化疗反应的反卷积分析和预测
bioRxiv. 2025 Jan 8:2024.12.09.627518. doi: 10.1101/2024.12.09.627518.
6
Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer.为他人带来希望:匹兹堡大学乳腺癌快速尸检项目的研究成果
bioRxiv. 2025 Mar 12:2024.11.06.621982. doi: 10.1101/2024.11.06.621982.
7
PEPerMINT: peptide abundance imputation in mass spectrometry-based proteomics using graph neural networks.PEPerMINT:基于图神经网络的质谱蛋白质组学中肽丰度推断。
Bioinformatics. 2024 Sep 1;40(Suppl 2):ii70-ii78. doi: 10.1093/bioinformatics/btae389.
8
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.多区域非小细胞肺癌患者衍生异种移植模型中基因组肿瘤内异质性的表现。
Nat Commun. 2024 May 31;15(1):4653. doi: 10.1038/s41467-024-47547-3.
9
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.评估患者来源异种移植物的生长和抗肿瘤活性:NCI PDXNet 共识建议。
Mol Cancer Ther. 2024 Jul 2;23(7):924-938. doi: 10.1158/1535-7163.MCT-23-0471.
10
Landscape of unconventional γδ T cell subsets in cancer.癌症中非传统 γδ T 细胞亚群的全景。
Mol Biol Rep. 2024 Jan 30;51(1):238. doi: 10.1007/s11033-024-09267-1.
肿瘤相关巨噬细胞在肿瘤免疫中的作用。
Front Immunol. 2020 Dec 3;11:583084. doi: 10.3389/fimmu.2020.583084. eCollection 2020.
4
Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells.调节性 T 细胞通过拮抗 IFN-γ 依赖性的骨髓细胞功能重编程来支持乳腺癌的进展。
Cell Rep. 2020 Dec 8;33(10):108482. doi: 10.1016/j.celrep.2020.108482.
5
The Gene Ontology resource: enriching a GOld mine.基因本体论资源:丰富一个 GOld 矿。
Nucleic Acids Res. 2021 Jan 8;49(D1):D325-D334. doi: 10.1093/nar/gkaa1113.
6
Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors.对乳腺癌患者来源异种移植瘤的化学基因组学分析揭示了难治性肿瘤的可靶向弱点。
Commun Biol. 2020 Jun 16;3(1):310. doi: 10.1038/s42003-020-1042-x.
7
Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.系统建立在患者来源异种移植实验和分析中的稳健性和标准。
Cancer Res. 2020 Jun 1;80(11):2286-2297. doi: 10.1158/0008-5472.CAN-19-3101. Epub 2020 Mar 9.
8
Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software.基于无参 DNA 甲基化去卷积软件比较分析的细胞类型异质性定量指南。
BMC Bioinformatics. 2020 Jan 13;21(1):16. doi: 10.1186/s12859-019-3307-2.
9
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.癌症相关成纤维细胞:抗肿瘤免疫治疗的一个新兴靶点。
J Hematol Oncol. 2019 Aug 28;12(1):86. doi: 10.1186/s13045-019-0770-1.
10
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.通过 RNA-seq 数据解析揭示的肿瘤免疫微环境的分子和药理学调节剂。
Genome Med. 2019 May 24;11(1):34. doi: 10.1186/s13073-019-0638-6.